Venous Thromboembolism Prevention During Asparaginase-Based Therapy for Acute Lymphoblastic Leukemia
Abstract
Share and Cite
Sibai, H.; Seki, J.T.; Wang, T.Q.; Sakurai, N.; Atenafu, E.G.; Yee, K.W.L.; Schuh, A.C.; Gupta, V.; Minden, M.D.; Schimmer, A.D.; et al. Venous Thromboembolism Prevention During Asparaginase-Based Therapy for Acute Lymphoblastic Leukemia. Curr. Oncol. 2016, 23, 355-361. https://0-doi-org.brum.beds.ac.uk/10.3747/co.23.3077
Sibai H, Seki JT, Wang TQ, Sakurai N, Atenafu EG, Yee KWL, Schuh AC, Gupta V, Minden MD, Schimmer AD, et al. Venous Thromboembolism Prevention During Asparaginase-Based Therapy for Acute Lymphoblastic Leukemia. Current Oncology. 2016; 23(4):355-361. https://0-doi-org.brum.beds.ac.uk/10.3747/co.23.3077
Chicago/Turabian StyleSibai, H., J.T. Seki, T.Q. Wang, N. Sakurai, E.G. Atenafu, K.W.L. Yee, A.C. Schuh, V. Gupta, M.D. Minden, A.D. Schimmer, and et al. 2016. "Venous Thromboembolism Prevention During Asparaginase-Based Therapy for Acute Lymphoblastic Leukemia" Current Oncology 23, no. 4: 355-361. https://0-doi-org.brum.beds.ac.uk/10.3747/co.23.3077